OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Physical exercise and liver “fitness”: Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease
Jelena Stevanović, Jorge Beleza, Pedro Coxito, et al.
Molecular Metabolism (2019) Vol. 32, pp. 1-14
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Mitochondrial alterations in fatty liver diseases
Bernard Fromenty, Michael Roden
Journal of Hepatology (2022) Vol. 78, Iss. 2, pp. 415-429
Open Access | Times Cited: 200

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
Oriol Juanola, Sebastián Martínez‐López, Rubén Francés, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 10, pp. 5227-5227
Open Access | Times Cited: 198

Liver Zonation – Revisiting Old Questions With New Technologies
Rory P. Cunningham, Natalie Porat‐Shliom
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 117

Epigenetics in NAFLD/NASH: Targets and therapy
Nalini Sodum, Gautam Kumar, Sree Lalitha Bojja, et al.
Pharmacological Research (2021) Vol. 167, pp. 105484-105484
Closed Access | Times Cited: 104

Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy
Youwei Zheng, Shiting Wang, Jialiang Wu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 52

Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 30

Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5375-5375
Open Access | Times Cited: 92

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
Aigli‐Ioanna Legaki, Ioannis I. Moustakas, Michalina Sikorska, et al.
Current Obesity Reports (2022) Vol. 11, Iss. 3, pp. 126-143
Open Access | Times Cited: 55

Impact of Physical Activity and Exercise on the Epigenome in Skeletal Muscle and Effects on Systemic Metabolism
Julio Plaza‐Díaz, David Izquierdo, Álvaro Torres-Martos, et al.
Biomedicines (2022) Vol. 10, Iss. 1, pp. 126-126
Open Access | Times Cited: 40

Cdo1-Camkk2-AMPK axis confers the protective effects of exercise against NAFLD in mice
Min Chen, Jieying Zhu, Wang-Jing Mu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 27

Molecular adaptations in response to exercise training are associated with tissue-specific transcriptomic and epigenomic signatures
Venugopalan D. Nair, Hanna Pinças, Gregory R. Smith, et al.
Cell Genomics (2024) Vol. 4, Iss. 6, pp. 100421-100421
Open Access | Times Cited: 14

Mitochondrial targeted therapy in MAFLD
Sien Lai, Dongsheng Tang, Juan Feng
Biochemical and Biophysical Research Communications (2025) Vol. 753, pp. 151498-151498
Closed Access | Times Cited: 1

Non-pharmacological management options for MAFLD: a practical guide
José Tadeu Stefano, Sebastião Mauro Bezerra Duarte, Renato Gama Ribeiro Leite Altikes, et al.
Therapeutic Advances in Endocrinology and Metabolism (2023) Vol. 14
Open Access | Times Cited: 21

Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
Ignazio Grattagliano, Liliana P. Montezinho, Paulo J. Oliveira, et al.
Biochemical Pharmacology (2018) Vol. 160, pp. 34-45
Open Access | Times Cited: 54

Exercise mitigates age-related metabolic diseases by improving mitochondrial dysfunction
Dandan Jia, Zhenjun Tian, Ru Wang
Ageing Research Reviews (2023) Vol. 91, pp. 102087-102087
Closed Access | Times Cited: 15

Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms
James Westley Heinle, Kara DiJoseph, Angelo Sabag, et al.
Nutrients (2023) Vol. 15, Iss. 11, pp. 2452-2452
Open Access | Times Cited: 14

The effect of exercise interventions on resting metabolic rate: A systematic review and meta-analysis
Kristen MacKenzie‐Shalders, Jaimon T. Kelly, Daniel So, et al.
Journal of Sports Sciences (2020) Vol. 38, Iss. 14, pp. 1635-1649
Open Access | Times Cited: 39

Epigenetics of Hepatic Insulin Resistance
Hannah Maude, Claudia Sanchez-Cabanillas, Inês Cebola
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 32

Deciphering the role of aberrant DNA methylation in NAFLD and NASH
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, et al.
Heliyon (2022) Vol. 8, Iss. 10, pp. e11119-e11119
Open Access | Times Cited: 19

Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish
Yun-Yi Zou, Xiang-bin Tang, Zhanglin Chen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 11

The emerging significance of mitochondrial targeted strategies in NAFLD treatment
Tao Zhang, Yingli Nie, Jiliang Wang
Life Sciences (2023) Vol. 329, pp. 121943-121943
Closed Access | Times Cited: 11

Mitochondrial function: A new direction for the targeted treatment of cardiovascular diseases with Chinese herbal medicine
Lin Yang, Liang Wang, Baofeng Yang, et al.
Journal of Holistic Integrative Pharmacy (2025) Vol. 6, Iss. 1, pp. 91-104
Open Access

Page 1 - Next Page

Scroll to top